Northern Trust
CYT

Northern Trust’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Northern Trust’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-68,283
Closed -$208K – 4512
2023
Q4 		$208K Buy
68,283
+34,094
+100% +$103K ﹤0.01% 3889
2023
Q3 		$97.1K Buy
34,189
+15,205
+80% +$41.9K ﹤0.01% 4022
2023
Q2 		$49.4K Hold
18,984
– – ﹤0.01% 4224
2023
Q1 		$34.6K Buy
18,984
+4,077
+27% +$6.62K ﹤0.01% 4348
2022
Q4 		$24.6K Buy
14,907
+1,732
+13% +$2.78K ﹤0.01% 4442
2022
Q3 		$25K Hold
13,175
– – ﹤0.01% 4512
2022
Q2 		$39K Sell
13,175
-125,069
-90% -$319K ﹤0.01% 4476
2022
Q1 		$521K Buy
138,244
+65,819
+91% +$375K ﹤0.01% 3724
2021
Q4 		$823K Sell
72,425
-758
-1% -$11.6K ﹤0.01% 3617
2021
Q3 		$1.28M Buy
+73,183
New +$1.37M ﹤0.01% 3471

Other funds holding CYT

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Northern Trust's CYT Position: Q1 2024 in Review

Northern Trust sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q1 2024, closing a stake of 68,283 shares — an estimated $208K sold.

Northern Trust first reported a position in CYT in Q3 2021 and held it in 10 quarters. The position peaked at $1.28M in Q3 2021. 4 funds tracked by Wall St. Rank hold CYT as of Q1 2024.

  • Northern Trust reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Northern Trust sold 68,283 Cyteir Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $208K.
  • Northern Trust first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Northern Trust's Cyteir Therapeutics, Inc. Common Stock position peaked at $1.28M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.